NextSDS Logo
Chemical Substance

6-glycidyloxynapht-1-yl oxymethyloxirane 603-113-00-9

CAS Number27610-48-6
EC Number429-960-2
Molecular FormulaC16H16O4
Screen your chemical compliance

Free 10-second scan. Upload a document and check compliance instantly.

Scan Now

Identifiers

Cas Number27610-48-6Primary
Ec Number429-960-2
Chemical Name1,6-BIS(2,3-EPOXYPROPOXY)NAPHTHALENE
Chemical Name6-glycidyloxynapht-1-yl oxymethyloxirane 603-113-00-9

GHS Hazard Pictograms

GHS08 Hazard PictogramGHS08
GHS07 Hazard PictogramGHS07

Hazard Classifications

Acute Tox. 4
Acute toxicity (oral + dermal + inhalation)
Warning
Hazard CodeH302 + H312 + H332
CategoryAcute Tox. 4
Source: Harmonised C&L
Skin Irrit. 2
Skin irritation
Warning
Hazard CodeH315
CategorySkin Irrit. 2
Source: Harmonised C&L
Skin Sens. 1
Skin sensitisation
Warning
Hazard CodeH317
CategorySkin Sens. 1
Source: Harmonised C&L
Muta. 2
Germ cell mutagenicity
Warning
Hazard CodeH341
CategoryMuta. 2
Source: Harmonised C&L
Aquatic Chronic 3
Hazardous to the aquatic environment (long-term)
Hazard CodeH412
CategoryAquatic Chronic 3
Source: Harmonised C&L

Regulatory Lists (3)

GLOBAL AUTOMOTIVE DECLARABLE SUBSTANCE LIST (GADSL)
Global Automotive Declarable Substance List (GADSL) — Industry-wide list of declarable and prohibited substances in automotive manufacturing
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out
EU COSMETIC PRODUCTS REGULATION: PROHIBITED SUBSTANCES
EU Cosmetic Products Regulation: Prohibited Substances — Substances prohibited in cosmetic products under Annex II of Regulation (EC) No 1223/2009

Manage Your Chemicals

Track substances, monitor regulatory changes, and stay compliant.

Try NextSDS Free

Related Substances

[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-2,2-dimethyl-3-[2-[2-[(3S,7S,11R)-3,7,11,15-tetramethylhexadecanoyl]sulfanylethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
146622-45-9
[5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-3-[2-[2-(2-hydroxy-3,7,11,15-tetramethyl-hexadecanoyl)sulfanylethylcarbamoyl]ethylcarbamoyl]-2,2-dimethyl-propoxy]-phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
172787-73-4
[5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-3-[2-[2-(3-hydroxy-2-methyl-butanoyl)sulfanylethylcarbamoyl]ethylcarbamoyl]-2,2-dimethyl-propoxy]-phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
52227-66-4
6-methoxy-3,3-dimethylhex-1-yne
843612-38-4
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-3-[2-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]sulfanylethylcarbamoyl]ethylcarbamoyl]-2,2-dimethyl-propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
119785-99-8

Disclaimer

The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.